Standout Papers

Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their A... 2012 2026 2016 2021 401
  1. Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas (2012)
    Piro Lito, Christine A. Pratilas et al. Cancer Cell
  2. CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors (2014)
    Sadhna Vora, Dejan Juric et al. Cancer Cell
  3. Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study (2018)
    Dejan Juric, Jordi Rodón et al. Journal of Clinical Oncology

Citation Impact

7 by Nobel laureates 21 from Science/Nature 62 standout
Sub-graph 1 of 16

Citing Papers

Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
17 intermediate papers

Works of Alan Huang being referenced

CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
2014 Standout
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
2012 Standout
and 1 more

Author Peers

Author Molecular Biology Oncology PRM Last Decade Papers Cites
Alan Huang 2186 1257 903 63 3.2k
Anand Maurya 90 13 17 22 352
C. Büchen‐Osmond 65 3 1 5 167
Haruo Aramoto 43 16 158 14 320
Ingo Besenthal 18 12 35 9 284
Vabitha Shetty 9 1 8 28 291

All Works

Loading papers...

Rankless by CCL
2026